跳转至内容
Merck
CN
  • Enhanced formation of giant cells in common variable immunodeficiency: Relation to granulomatous disease.

Enhanced formation of giant cells in common variable immunodeficiency: Relation to granulomatous disease.

Clinical immunology (Orlando, Fla.) (2016-11-20)
Timothy H Scott-Taylor, Karen Whiting, Ruth Pettengell, David A Webster
摘要

Peripheral monocytes from patients with common variable immunodeficiency (CVID) had on average a 2 fold greater tendency to form giant cells in medium without additional cytokines. Giant cell formation was faster and 3 to 5 fold higher in most CVID cells compared to normal. Addition of IL4, GMCSF, IFNγ, TNFa and both T cell and monocyte conditioned media promoted monocyte fusion of some CVID individuals over 5 fold the normal average level, with combinations of cytokines and monokines acting synergistically. The reduction of normal giant cell formation by anti-IFNγ antibody and a greater tendency of CVID cells to fuse in immunoglobulin conditioned media suggests that standard IVIg treatment contributes to granuloma formation. CVID and normal giant cells expressed similar levels of phenotypic molecules and had similar phagocytic activity. Monocytes from many CVID patients have an elevated tendency to fuse which may explain the high incidence of granulomatous complications in CVID.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
PMA, for use in molecular biology applications, ≥99% (HPLC), Molecular Biology
Sigma-Aldrich
多聚-L-赖氨酸 溶液, mol wt 150,000-300,000, 0.01%, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
I型胶原蛋白 溶液 来源于大鼠尾, BioReagent, suitable for cell culture, sterile-filtered
Sigma-Aldrich
皂素, Molecular Biology, used as non-ionic surfactant
Sigma-Aldrich
鬼笔环肽,异硫氰酸荧光素标记, sequence Amanita phalloides(synthetic: peptide sequence)
Sigma-Aldrich
细胞松驰素D, Ready Made Solution, from Zygosporium mansonii, 5 mg/mL in DMSO
Sigma-Aldrich
来自 菜豆的凝集素 (红芸豆), Leucoagglutinin PHA-L, lyophilized powder
Sigma-Aldrich
6-膦酰己酸, 97%